I26 I80 C34
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: - Age = 40 years - Indication for anatomical lung resection - Detected or suspected lung carcinoma - Information and signed consent - The use of antiplatelet drugs (e.g. ASS, Clopidogrel) is permitted
Exclusion criteria
Exclusion criteria: - VTE in medical history within the last 12 months - severe coagulation disorder (PTT > 40s, Quick 1.5, thrombocytes 1.15 mg/dl for men and 0.95 mg/dl for women) - Known coagulopathy - Existing drug anticoagulation - Contrast agent allergy - Hyperthyroidism - Pregnancy and lactation
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Rate of patients with adequate prophylactic anti factor Xa level (0.3 - 0.5 U/ml) on the 3rd postoperative day reciving VTE prophylaxis with 40mg enoxaparin | — |
Secondary
| Measure | Time frame |
|---|---|
| - Rate of postoperative deep vein thrombosis - Rate of postoperative pulmonary embolisms - Rate of postoperative venous thrombembolisms - Influence of anti-factor Xa level on the incidence of venous thrombembolism - Influence of patient characteristics (BMI, gender, renal function) on antifactor Xa activity and incidence of venous thrombembolism - Postoperative complications, especially intra- and postoperative bleeding | — |
Countries
Germany
Contacts
St. Hildegardis Krankenhaus, Thoraxklinik